Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus

  • Tessa E. Fuhrer
  • , Thulani H. Palpagama
  • , Henry J. Waldvogel
  • , Beth J.L. Synek
  • , Clinton Turner
  • , Richard L. Faull
  • , Andrea Kwakowsky

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

73 Citations (Scopus)

Abstract

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain and plays an important role in regulating neuronal excitability. GABA reuptake from the synapse is dependent on specific transporters – mainly GAT-1, GAT-3 and BGT-1 (GATs). This study is the first to show alterations in the expression of the GATs in the Alzheimer's disease (AD) hippocampus, entorhinal cortex and superior temporal gyrus. We found a significant increase in BGT-1 expression associated with AD in all layers of the dentate gyrus, in the stratum oriens of the CA2 and CA3 and the superior temporal gyrus. In AD there was a significant decrease in GAT-1 expression in the entorhinal cortex and superior temporal gyrus. We also found a significant decrease in GAT-3 immunoreactivity in the stratum pyramidale of the CA1 and CA3, the subiculum and entorhinal cortex. These observations indicate that the expression of the GATs shows brain-region- and layer-specific alterations in AD, suggesting a complex activation pattern of different GATs during the course of the disease.

Original languageEnglish
Pages (from-to)108-118
Number of pages11
JournalNeuroscience
Volume351
DOIs
Publication statusPublished - 20 May 2017
Externally publishedYes

Keywords

  • Alzheimer's disease
  • GABA
  • GABA transporters
  • human brain

Fingerprint

Dive into the research topics of 'Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus'. Together they form a unique fingerprint.

Cite this